Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Jost

Showing results (361-370 of 384) with videos related to

Pageof 39
Sort By:
Neurology|February 1, 2013
Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complicationsAlexander Storch, Christine B Schneider, Martin Wolz, et al.
Fortschritte Der Neurologie-Psychiatrie|April 22, 2022
[Treatment of Sialorrhea with Botulinum Neurotoxin Type A - Consensus Practice Recommendations for Children and Adults]Wolfgang H Jost, Tobias Bäumer, Andrea Bevot, et al.
Fortschritte Der Neurologie-Psychiatrie|June 15, 2022
[Correction: Treatment of Sialorrhea with Botulinum Neurotoxin Type A - Consensus Practice Recommendations for Children and Adults]Wolfgang H Jost, Tobias Bäumer, Andrea Bevot, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 30, 2016
The asphericity of the metabolic tumour volume in NSCLC: correlation with histopathology and molecular markersIvayla Apostolova, Kilian Ego, Ingo G Steffen, et al.
European Radiology|November 13, 2015
Dual time point imaging for F18-FDG-PET/CT does not improve the accuracy of nodal staging in non-small cell lung cancer patientsJulian M M Rogasch, Ingo G Steffen, Sandra Riedel, et al.
European Journal of Radiology|July 18, 2016
Standardized visual reading of F18-FDG-PET in patients with non-small cell lung cancer scheduled for preoperative thoracic lymph node stagingJulian M M Rogasch, Ivayla Apostolova, Ingo G Steffen, et al.
Neuroimage. Clinical|April 21, 2024
The connection of motor improvement after deep brain stimulation in Parkinson's disease and microstructural integrity of the substantia nigra and subthalamic nucleusMarco G Hermann, Nils Schröter, Alexander Rau, et al.
Archives of Neurology|May 16, 2007
Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson diseaseAlexander Storch, Wolfgang H Jost, Peter Vieregge, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 29, 2010
Utility of the WHO-Five Well-being Index as a screening tool for depression in Parkinson's diseaseChristine B Schneider, Maximilian Pilhatsch, Martina Rifati, et al.
BMC Cancer|September 16, 2020
Plasma-based longitudinal mutation monitoring as a potential predictor of disease progression in subjects with adenocarcinoma in advanced non-small cell lung cancerJohn Jiang, Hans-Peter Adams, Maria Lange, et al.
Pageof 39

Showing results (361-370 of 384) with videos related to

Sort By:
Pageof 39
Neurology|February 1, 2013
Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complicationsAlexander Storch, Christine B Schneider, Martin Wolz, et al.
Fortschritte Der Neurologie-Psychiatrie|April 22, 2022
[Treatment of Sialorrhea with Botulinum Neurotoxin Type A - Consensus Practice Recommendations for Children and Adults]Wolfgang H Jost, Tobias Bäumer, Andrea Bevot, et al.
Fortschritte Der Neurologie-Psychiatrie|June 15, 2022
[Correction: Treatment of Sialorrhea with Botulinum Neurotoxin Type A - Consensus Practice Recommendations for Children and Adults]Wolfgang H Jost, Tobias Bäumer, Andrea Bevot, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 30, 2016
The asphericity of the metabolic tumour volume in NSCLC: correlation with histopathology and molecular markersIvayla Apostolova, Kilian Ego, Ingo G Steffen, et al.
European Radiology|November 13, 2015
Dual time point imaging for F18-FDG-PET/CT does not improve the accuracy of nodal staging in non-small cell lung cancer patientsJulian M M Rogasch, Ingo G Steffen, Sandra Riedel, et al.
European Journal of Radiology|July 18, 2016
Standardized visual reading of F18-FDG-PET in patients with non-small cell lung cancer scheduled for preoperative thoracic lymph node stagingJulian M M Rogasch, Ivayla Apostolova, Ingo G Steffen, et al.
Neuroimage. Clinical|April 21, 2024
The connection of motor improvement after deep brain stimulation in Parkinson's disease and microstructural integrity of the substantia nigra and subthalamic nucleusMarco G Hermann, Nils Schröter, Alexander Rau, et al.
Archives of Neurology|May 16, 2007
Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson diseaseAlexander Storch, Wolfgang H Jost, Peter Vieregge, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 29, 2010
Utility of the WHO-Five Well-being Index as a screening tool for depression in Parkinson's diseaseChristine B Schneider, Maximilian Pilhatsch, Martina Rifati, et al.
BMC Cancer|September 16, 2020
Plasma-based longitudinal mutation monitoring as a potential predictor of disease progression in subjects with adenocarcinoma in advanced non-small cell lung cancerJohn Jiang, Hans-Peter Adams, Maria Lange, et al.
Pageof 39